It ends in court — next year. Blake Lively and Justin Baldoni are headed to trial on March 9, 2026 to settle their “It Ends With Us” legal dispute. The court date for the case was scheduled ...

A Phase III trial demonstrated that adding nivolumab, an immunotherapy drug, to pre-surgery chemotherapy significantly improves cure rates for ER+/HER2− breast cancer, the most common subtype.

A petition supporting the Prince Charles Cinema was launched after the management said it believed its future was under threat, due to new terms being imposed by its landlord. It says the building ...

The Prince Charles Cinema, one of the few independent cinemas in central London, has accused its landlord of “intimidation” over a proposed clause in its lease which would require it to leave ...

King Charles appeared emotional today as he joined world leaders in Poland to commemorate 80 years since the liberation of Auschwitz-Birkenau. In what was the first visit by a British monarch to ...

Charles has become the first British head of state to visit the former Nazi concentration camp where he he sat with other world leaders to mark 80 years since its liberation. Survivors were applauded ...

Justin Baldoni and Blake Lively could be headed for a trial on March 9, 2026, a judge said on Monday. The “It Ends With Us” co-stars are suing each other in federal court in New York.

As Prince William and Princess Kate attend a special ceremony in London, Charles is in Poland on the 80th anniversary of the Auschwitz-Birkenau liberation Simon Perry is a writer and correspondent ...

While His Majesty didn't pull on his running trainers for the occasion, Charles met the Sandringham parkrunners in the café on his Norfolk estate on Saturday. In a photograph shared by parkrun UK ...

A moved King Charles has made history by becoming the first British monarch to visit Auschwitz for an emotional ceremony to commemorate the 80th anniversary of its liberation. Charles has headed ...

Europe's largest pharmaceutical firm, Novo Nordisk, revealed positive trial results for its next-generation obesity drug, amycretin, marking a major step in its competition within the increasingly ...